Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-16

Clinical Trial Update: Implementation of Teledermoscopy and Artificial Intelligence

View source ↗

Summary

A clinical trial evaluating teledermoscopy and artificial intelligence for skin cancer is currently recruiting. The sponsor is Region Skane.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Region Skane | Conditions: Skin Cancer | Status: RECRUITING